211 related articles for article (PubMed ID: 1639067)
1. Identification of a stage selector element in the human gamma-globin gene promoter that fosters preferential interaction with the 5' HS2 enhancer when in competition with the beta-promoter.
Jane SM; Ney PA; Vanin EF; Gumucio DL; Nienhuis AW
EMBO J; 1992 Aug; 11(8):2961-9. PubMed ID: 1639067
[TBL] [Abstract][Full Text] [Related]
2. Maximal activity of an erythroid-specific enhancer requires the presence of specific protein binding sites in linked promoters.
Amrolia PJ; Gabbard W; Cunningham JM; Jane SM
J Biol Chem; 1998 May; 273(22):13593-8. PubMed ID: 9593696
[TBL] [Abstract][Full Text] [Related]
3. Methylation-enhanced binding of Sp1 to the stage selector element of the human gamma-globin gene promoter may regulate development specificity of expression.
Jane SM; Gumucio DL; Ney PA; Cunningham JM; Nienhuis AW
Mol Cell Biol; 1993 Jun; 13(6):3272-81. PubMed ID: 7684493
[TBL] [Abstract][Full Text] [Related]
4. Gamma-globin gene promoter elements required for interaction with globin enhancers.
Langdon SD; Kaufman RE
Blood; 1998 Jan; 91(1):309-18. PubMed ID: 9414299
[TBL] [Abstract][Full Text] [Related]
5. Sequences located 3' to the breakpoint of the hereditary persistence of fetal hemoglobin-3 deletion exhibit enhancer activity and can modify the developmental expression of the human fetal A gamma-globin gene in transgenic mice.
Anagnou NP; Perez-Stable C; Gelinas R; Costantini F; Liapaki K; Constantopoulou M; Kosteas T; Moschonas NK; Stamatoyannopoulos G
J Biol Chem; 1995 Apr; 270(17):10256-63. PubMed ID: 7537267
[TBL] [Abstract][Full Text] [Related]
6. Development of viral vectors for gene therapy of beta-chain hemoglobinopathies: optimization of a gamma-globin gene expression cassette.
Li Q; Emery DW; Fernandez M; Han H; Stamatoyannopoulos G
Blood; 1999 Apr; 93(7):2208-16. PubMed ID: 10090929
[TBL] [Abstract][Full Text] [Related]
7. Identification of upstream regulatory elements that repress expression of adult beta-like globin genes in a primitive erythroid environment.
Ebb D; Tang DC; Drew L; Chin K; Berg PE; Rodgers GP
Blood Cells Mol Dis; 1998 Sep; 24(3):356-69. PubMed ID: 10087993
[TBL] [Abstract][Full Text] [Related]
8. Identification of a major positive regulatory element located 5' to the human zeta-globin gene.
Sabath DE; Koehler KM; Yang WQ; Patton K; Stamatoyannopoulos G
Blood; 1995 May; 85(9):2587-97. PubMed ID: 7727787
[TBL] [Abstract][Full Text] [Related]
9. The roles of 5'-HS2, 5'-HS3, and the gamma-globin TATA, CACCC, and stage selector elements in suppression of beta-globin expression in early development.
Sargent TG; DuBois CC; Buller AM; Lloyd JA
J Biol Chem; 1999 Apr; 274(16):11229-36. PubMed ID: 10196210
[TBL] [Abstract][Full Text] [Related]
10. Regulated expression of the human beta globin gene in transgenic mice requires an upstream globin or nonglobin promoter.
Anderson KP; Lloyd JA; Ponce E; Crable SC; Neumann JC; Lingrel JB
Mol Biol Cell; 1993 Oct; 4(10):1077-85. PubMed ID: 8298193
[TBL] [Abstract][Full Text] [Related]
11. Activation of delta-globin gene expression by erythroid Krupple-like factor: a potential approach for gene therapy of sickle cell disease.
Donze D; Jeancake PH; Townes TM
Blood; 1996 Nov; 88(10):4051-7. PubMed ID: 8916973
[TBL] [Abstract][Full Text] [Related]
12. Augmentation of gamma-globin gene promoter activity by carboxylic acids and components of the human beta-globin locus control region.
Safaya S; Ibrahim A; Rieder RF
Blood; 1994 Dec; 84(11):3929-35. PubMed ID: 7949149
[TBL] [Abstract][Full Text] [Related]
13. Identification of two novel regulatory elements within the 5'-untranslated region of the human A gamma-globin gene.
Amrolia PJ; Cunningham JM; Ney P; Nienhuis AW; Jane SM
J Biol Chem; 1995 May; 270(21):12892-8. PubMed ID: 7759548
[TBL] [Abstract][Full Text] [Related]
14. Activation of the delta-globin gene by the beta-globin gene CACCC motif.
Ristaldi MS; Casula S; Porcu S; Marongiu MF; Pirastu M; Cao A
Blood Cells Mol Dis; 1999; 25(3-4):193-209. PubMed ID: 10575545
[TBL] [Abstract][Full Text] [Related]
15. HS2 enhancer function is blocked by a transcriptional terminator inserted between the enhancer and the promoter.
Ling J; Ainol L; Zhang L; Yu X; Pi W; Tuan D
J Biol Chem; 2004 Dec; 279(49):51704-13. PubMed ID: 15465832
[TBL] [Abstract][Full Text] [Related]
16. Requirements for utilization of CREB binding protein by hypersensitive site two of the beta-globin locus control region.
Johnson KD; Norton JE; Bresnick EH
Nucleic Acids Res; 2002 Apr; 30(7):1522-30. PubMed ID: 11917012
[TBL] [Abstract][Full Text] [Related]
17. A (GATA)(7) motif located in the 5' boundary area of the human beta-globin locus control region exhibits silencer activity in erythroid cells.
Ramchandran R; Bengra C; Whitney B; Lanclos K; Tuan D
Am J Hematol; 2000 Sep; 65(1):14-24. PubMed ID: 10936858
[TBL] [Abstract][Full Text] [Related]
18. Single-copy transduction and expression of human gamma-globin in K562 erythroleukemia cells using recombinant adeno-associated virus vectors: the effect of mutations in NF-E2 and GATA-1 binding motifs within the hypersensitivity site 2 enhancer.
Miller JL; Walsh CE; Ney PA; Samulski RJ; Nienhuis AW
Blood; 1993 Sep; 82(6):1900-6. PubMed ID: 8400240
[TBL] [Abstract][Full Text] [Related]
19. Genomic footprinting and sequencing of human beta-globin locus. Tissue specificity and cell line artifact.
Reddy PM; Stamatoyannopoulos G; Papayannopoulou T; Shen CK
J Biol Chem; 1994 Mar; 269(11):8287-95. PubMed ID: 8132552
[TBL] [Abstract][Full Text] [Related]
20. Activation of the beta-globin promoter by the locus control region correlates with binding of a novel factor to the CAAT box in murine erythroleukemia cells but not in K562 cells.
Delvoye NL; Destroismaisons NM; Wall LA
Mol Cell Biol; 1993 Nov; 13(11):6969-83. PubMed ID: 8413287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
